Hypertension in children with obesity: a practical guide to diagnosis and treatment
Authors:
Bohuslav Procházka 1; Tomáš Seeman 2,3
Authors‘ workplace:
MUDr. Bohuslav Procházka s. r. o., Dětská kardiologie, Kutná Hora
1; Pediatrická klinika, 2. lékařská fakulta, Univerzita Karlova, Fakultní nemocnice Motol a Homolka, Praha
2; Klinika dětského lékařství, Lékařská fakulta, Ostravská univerzita, Fakultní nemocnice Ostrava
3
Published in:
Čes-slov Pediat 2026; 81 (Supplementum): 20-27.
Category:
doi:
https://doi.org/10.55095/CSPediatrie2026/022
Overview
The article emphasizes the importance of early recognition of arterial hypertension in children with obesity and highlights the need for targeted therapeutic interventions. Obesity in children, frequently associated with hypertension, is a major risk factor for the development of cardiovascular disease, with clinical manifestations that may appear as early as the third or fourth decade of life. In combination with other metabolic complications, it may result in substantial organ damage and an unfavourable long-term prognosis. The article also provides practical recommendations for the diagnosis and management of hypertension in children and adolescents with obesity, including the basic steps of pharmacological therapy and lifestyle interventions that are essential for preventing future health consequences.
Keywords:
obesity – prevention – hypertension – cardiovascular diseases – treatment – children
Sources
1. Enos WF, Holmes RH, Beyer J. Coronary disease among United States soldiers killed in action in Korea. JAMA 1953; 152(12): 1090–1093.
2. Kannel WB, Dawber TR, Kagan A, et al. Factors of risk in the development of coronary heart disease six year follow-up experience. The Framingham Study. Ann Intern Med 1961; 55 : 33–50.
3. Kannel WB, Brand N, Skinner JJ, et al. The relation of adiposity to blood pressure and development of hypertension. The Framingham Study. Ann Intern Med 1967; 67(1): 48–59.
4. Kannel WB, Dawber TR, Kannel C, et al. Interrelationship of risk factors in the development of coronary heart disease—An epidemiologic analysis of pooled Framingham data. Circulation 1961; 29 : 20–31.
5. Freedman DS, Dietz WH, Srinivasan SR, et al. The relation of overweight to cardiovascular risk factors among children and adolescents: The Bogalusa Heart Study. Pediatrics 1999; 103 : 1175–1182.
6. Must A, Jacques PF, Dallal GE, et al. Long-term morbidity and mortality of overweight adolescents: A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 1992; 327(19): 1350–1355.
7. Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006; 355 : 763–778.
8. Vliv restrikcí spojených s onemocněním covid-19 na prevalenci nadváhy a obezity u českých dětí Ces-slov Pediat 2023; 78(5): 275–280.
9. Procházka B, Kratěnová J, Žejglicová K, et al. Aktuální výskyt rizikových faktorů ischemické choroby srdeční u dětí v ČR v roce 2016. Čes-slov Pediat 2018; 73(8): 501–508.
10. Kotchen TA. Obesity-related hypertension: epidemiology, pathophysiology, and clinical management. Am J Hypertens. 2010.
11. Falkner B, Gidding SS, Portman R, et al. Blood pressure variability and classification of prehypertension and hypertension in adolescence. Pediatrics 2008; 122(2): 238–242.
12. Straznicky N, Eikelis N, Lambert E, et al. Mediators of sympathetic activation in metabolic syndrome obesity. Curr Hypertens Rep 2008; 10 : 440–447.
13. Daniels SR, Loggie JM, Khoury P, et al. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation 1998; 97 : 1907–1911.
14. Seeman T, Šuláková T, Stabouli S. masked hypertension in healthy children and adolescents: who should be screened? Curr Hypertens Rep 2023; 25(9): 231–242.
15. Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl.
16. Cueto V, Medvecky H, Funaro MC, Nugent JT. Accuracy of home blood pressure monitoring in youth: a systematic review and meta-analysis. J Pediatr 2025; 284 : 114633.
17. Lurbe E, Agabiti-Rosei E, Cruickshank JK. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens 2016; 34(10): 1887–1920.
18. Francesco C, Cappucio Taggart FM, Kandala NB, et al. Meta-analysis of short sleep duration and obesity in children and adults. Sleep 2008; 31(5): 619–626.
19. Ma Y, et al. High salt intake – independent risk factor for obesity. Hypertension 2015 : 66 : 843–9.
20. Janda, et al. ZSF České Budějovice 2020.
21. Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 2001; 344(1): 3–10.
22. Edwards JJ, Deenmamode AHP, Griffiths M, et al. Exercise training and resting blood pressure: a large-scale pairwise and network meta-analysis of randomised controlled trials. Br J Sports Med 2023; 57(20): 1317–1326.
23. Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 2017; 140(3): e20171904.
24. Jiang W, Hu C, Li F, et al. Association between sleep duration and high blood pressure in adolescents: a systematic review and meta-analysis. Ann Hum Biol 2018; 45(6–8): 457–462.
25. Borghi C, Cicero AF, Agnoletti D, Fiorini G. Pathophysiology of cough with angiotensin-converting enzyme inhibitors: How to explain within-class differences? Eur J Intern Med 2023; 110 : 10–15.
26. Seeman T, Kolský A, Šuláková T. Hypertenze u dětí a dorostenců. Čes-slov Pediat 2025; 80(1): 39–46.
27. Kanai H, Matsuzawa Y, Kotani K, et al. Close correlation of intra-abdominal fat accumulation to hypertension in obese women. Hypertension 1990; 16(5): 484–490.
28. Edwards JJ, Deenmamode AHP, Griffiths M, et al. Exercise training and resting blood pressure: a large-scale pairwise and network meta-analysis of randomised controlled trials. Br J Sports Med 2023; 57(20): 1317–1326.
29. Weghuber D, Barrett T, Barrientos Pérez M, et al. Once weekly semaglutide in adolescents with obesity. N Engl J Med 2022; 387(24): 22452257.
30. Kennedy C, Hayes P, Cicero AF, et al. Semaglutide and blood pressure: an individual patient data metaanalysis. Eur Heart J 2024; 45 : 41244134.
31. Burrello J, Erhardt EM, Saint-Hilary G, et al. Pharmacological treatment of arterial hypertension in children and adolescents: a network meta-analysis. Hypertension 2018; 72(2): 306–313.
Labels
Neonatology Paediatrics General practitioner for children and adolescentsArticle was published in
Czech-Slovak Pediatrics
2026 Issue Supplementum
Most read in this issue
- Glucose metabolism disorders in children and adolescents with obesity
- Diagnostic and therapeutic recommendations for dyslipidemia in children and adolescents with obesity
- Hypertension in children with obesity: a practical guide to diagnosis and treatment
- Vladimír Hanuš: Modré tělo v krajině (2008)